FY 25-26 performance

Share of revenue from India market
0 %
Compounded annual growth over (FY23-FY26)
0 %
Return on Capital Employed
%
 Revenue from operations
₹ 0 Cr
Earnings per share
₹
Compound annual total return to shareholders over the last 5 fiscal years
0 %
Total FY24 revenues, an increase of 2% in local currency
$ 0 B
FY24 adjusted EPS, a 2% increase over FY23 adjusted EPS; $11.44 FY24 GAAP EPS, a 6% increase.
$ 0
Compound annual total return to shareholders over the last 5 fiscal years
$ 0 B
FY24 cash returned to shareholders
$ 0 B
FY24 adjusted EPS, a 2% increase over FY23 adjusted EPS; $11.44 FY24 GAAP EPS, a 6% increase.
$ 0

Driving Sustainable Growth and Innovation

Emcure is committed to creating long-term value through innovation, operational excellence, and a steadfast focus on delivering impactful healthcare solutions. Guided by a strong foundation of integrity and performance, we strive to achieve sustainable growth while addressing critical medical needs globally.

Track all markets on TradingView

Annual Report FY 2024-25

Click here

Disclosure under Regulation 14 of SEBI (SBEB) Regulations for FY 2024-25

Click here

Annual Report FY 2023-24

Click here

Annual Report FY 2022-23

Click here

Annual Report FY 2021-22

Click here

Subsidaries FS FY 2024-25

Click here

Gennova Biopharmaceuticals Limited Financials March 2024

Click here

Zuventus Healthcare Limited Financials March 2024

Click here

Emcure UK INR Converted Financials FY 2024

Click here

Marcan INR Converted Financials FY 2024

Click here

Tillomed UK INR Converted Financials FY 2024

Click here

Gennova Biopharmaceuticals Ltd. – Financial Statement 2023

Click here

Gennova Biopharmaceuticals Ltd. – Financial Statement 2022

Click here

Gennova Biopharmaceuticals Ltd. – Financial Statement 2021

Click here

Zuventus Healthcare Ltd – Financial Statement 2023

Click here

Zuventus Healthcare Ltd – Financial Statement 2022

Click here

Zuventus Healthcare Ltd – Financial Statement 2021

Click here

Emcure UK INR Converted Financial

Click here

Tillomed UK INR Converted Financial

Click here

Marcan INR Converted Financial

Click here

Subsidaries FS FY 2024-25

Click here

Gennova Biopharmaceuticals Limited Financials March 2024

Click here

Zuventus Healthcare Limited Financials March 2024

Click here

Emcure UK INR Converted Financials FY 2024

Click here

Marcan INR Converted Financials FY 2024

Click here

Tillomed UK INR Converted Financials FY 2024

Click here

Gennova Biopharmaceuticals Ltd. – Financial Statement 2023

Click here

Gennova Biopharmaceuticals Ltd. – Financial Statement 2022

Click here

Gennova Biopharmaceuticals Ltd. – Financial Statement 2021

Click here

Zuventus Healthcare Ltd – Financial Statement 2023

Click here

Proceeding of Postal Ballot – 24th April, 2026

Click here

Voting Results of Postal Ballot along with Scrutinizer’s Report declared on 27th April, 2026

Click here

Notices under Sec. 160 of the CA, 2013 for FY 2025-26

Click here

Intimation of Notice of Postal Ballot dated 24th March, 2026

Click here

Notice of Postal Ballot – 24th March, 2026

Click here

Proceeding of Postal Ballot – 17th February, 2026

Click here

Voting Results of Postal Ballot along with Scrutinizer’s Report declared on 24th March, 2026

Click here

Intimation of Notice of Postal Ballot dated 17th February, 2026

Click here

Notice of Postal Ballot – 17th February, 2026

Click here

Voting Results of 44th Annual General Meeting along with Scrutinizer’s Report – 28th August 2025

Click here

Newspaper Publication of Audited Financial Results – Q4 and Year end FY26

Click here

Newspaper Publication of Audited Financial Results – Q4 and Year end FY25

Click here

Newspaper Publication of Postal Ballot Notice dated 17th February, 2026

Click here

Newspaper Publication of Unaudited Financial Results – Q3 FY26

Click here

Newspaper Publication of Unaudited Financial Results – Q2 FY26

Click here

Newspaper Publication of Unaudited Financial Results – Q1 FY26

Click here

Newspaper Publication of Notice of 44th Annual General Meeting – 28th August 2025

Click here

Newspaper Publication of Unaudited Financial Results – Q4 FY25

Click here

Newspaper Publication of Unaudited Financial Results – Q3 FY25

Click here

Newspaper Publication of Postal Ballot Notice – 7th November 2024

Click here

Credit Ratings

Click here

Credit Ratings

Rating Agency
Instrument Type
Rating

CRISIL Ratings Limited

Long Term Rating

CRISIL AA-/Positive (Upgraded from ‘CRISIL AA-/ Stable’)

Short Term Rating

CRISIL A1+ (Re-affirmed at CRISIL A1+)

CARE Ratings Limited

Long-term bank facilities

CARE AA; Stable (upgraded from CARE AA-; Stable)

Long-term / Short-term bank facilities

CARE AA; Stable / CARE A1+ (Long-term rating upgraded from CARE AA-; Stable and Short-term rating reaffirmed)

Short-term bank facilities

CARE A1+ (Reaffirmed)

Annual Secretarial Compliance Report FY 2025-26

Click here

Annual Secretarial Compliance Report FY 2024-25

Click here

Annual Return for FY 2023-24

Click here

Annual Return for FY 2024-25

Click here

Investor Presentation - June, 2026

Investor Presentation on 05 May, 2026

Investor Presentation for Analysts or Investors Meeting(s) on November 19 and 20, 2025

Click here

Click here

Click here

Quarterly Results

Q1

Board Meeting Intimation
Earnings Call Transcript

Q4

Quarterly Results
Board Meeting Intimation
Earnings Call Invite
Earnings Call Recording
Earnings Call Transcript

Q3

Quarterly Results
Board Meeting Intimation
Earnings Call Invite
Earnings Call Recording
Earnings Call Transcript

Q2

Quarterly Results
Board Meeting Intimation
Earnings Call Invite
Earnings Call Recording
Earnings Call Transcript

Q1

Quarterly Results
Board Meeting Intimation
Earnings Call Invite
Earnings Call Recording
Earnings Call Transcript

Presentations by the Company to Analysts or Institutional Investors

Click here

Details of Business

Click here

Brief profile of Board of Directors

Click here

Committees of the Board

Click here

Emcure – Memorandum and Articles of Association

Click here

Code of Conduct for Directors and Senior Management

Click here

Vigil Mechanism Policy

Click here

CSR Policy and Composition of CSR Committee

Click here

Nomination and Remuneration Policy

Click here

Archival Policy

Click here

Dividend Distribution Policy

Click here

Policy for Preservation of Documents

Click here

Policy for Determining Material Subsidiaries

Click here

Terms and Conditions of Appointment of Independent Director

Click here

Familiarisation Program for Independent Directors

Click here

Details of Familiarization Programme Imparted to Independent Directors

Click here

Policy for Determining Materiality of Events and Information for Disclosures

Click here

Related Party Transactions Policy

Click here

Code for Prohibition of Insider Trading – w.e.f. June 10, 2025

Click here

Emcure Code of Conduct

Click here

Human Rights Policy

Click here

Environment, Health and Safety Policy

Click here

Emcure – Employee Stock Option Scheme 2013

Click here

Shareholding Pattern

Click here

Disclosures under Regulation 30

Click here

Disclosures under Regulation 32

Click here

Corporate Governance Filings

Click here

Board Meeting Intimation

Click here

Financial Results

Click here

Financial Results published in Newspaper

Click here

Notices to Shareholders

Click here

Annual Report

Click here

Annual Returns

Click here

Annual Secretarial Compliance Report

Click here

Credit Ratings

Click here

Financial Statement of Subsidiary Companies

Click here

Schedule of analysts or institutional investors meet

Click here

Audio or video recordings and transcripts of post earnings/quarterly calls

Click here

Intimation under Regulation 30(5) – Details of KMPs

Click here

Email address for grievance redressal and other relevant details

Click here

Draft Red Herring Prospectus – 16th December, 2023

Click here

Addendum to Draft Red Herring Prospectus – 18.03.2024

Click here

Red Herring Prospectus – 26th June, 2024

Click here

Prospectus – 5th July, 2024

Click here

Loading...

Loading...

Statement of Deviation or Variation Q2 FY25

Click here

Monitoring Agency Report Q2 FY25

Click here

Loading...

Disclosure on Related Party Transactions for half year ended March 31, 2026

Click here

Disclosure on Related Party Transactions for half year ended September 30, 2025

Click here

Disclosure on Related Party Transactions for half year ended March 31, 2025

Click here

Disclosure on Related Party Transactions for half year ended September 30, 2024

Click here

Intimation of closure of Trading Window – Q1 FY27

Click here

Intimation of closure of Trading Window – Q4 FY26

Click here

Intimation of closure of Trading Window – Q3 FY26

Click here

Intimation of change in email address of Registrar and Share Transfer Agent of the Company

Click here

Intimation of closure of Trading Window – Q2 FY26

Click here

Intimation of closure of Trading Window – Q1 FY26

Click here

Disclosure of KPIs under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018

Click here

Intimation of change in email and website address of Registrar and Share Transfer Agent of the Company

Click here

Intimation of closure of Trading Window – Q4 FY25

Click here

Intimation of change in name of Registrar and Share Transfer Agent of the Company

Click here

Intimation of closure of Trading Window – Q3 FY25

Click here

Intimation of closure of Trading Window – Q2 FY25

Click here

Intimation of closure of Trading Window

Click here

Unpaid dividend details for Final Dividend for FY 2024-25

Click here

Request for Registering PAN, Mobile Number, E-mail address, other KYC details or changes/updation thereof (Form ISR-1)

Click here

Updation of signature of Shareholder (Form ISR-2)

Click here

Declaration Form for opting-out of Nomination by holders of physical securities (Form ISR-3)

Click here

Request for issue of duplicate certificate and other services (Form ISR-4)

Click here

Nomination Form (Form SH-13)

Click here

Cancellation or Variation of Nomination (Form SH-14)

Click here

SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 – March 16, 2023

Click here

SEBI/HO/MIRSD/POD-1/P/CIR/2023/181 – November 17, 2023

Click here

Loading...

Form No. 10F

Click here

Form No. 15G

Click here

Form No. 15H

Click here

Beneficial Ownership Declaration

Click here

Information under Rule 37bc of Income Tax Rules 1962

Click here

Self Declaration Form

Click here

SEBI
In case the Complaint/grievance stands unresolved/not resolved up to the satisfaction of Investor(s), may lodge a complaint with:

SEBI SCORES Portal: https://scores.gov.in/scores/Welcome.html

Online Dispute Resolution (Smart ODR) Platform: https://smartodr.in/login